Teitze syndrome: costochondritis of the chest wall with joint swelling Skin and Connective Tissue Diseases
Conditions
Interventions
The intervention group will have oral corticosteroid therapy for a short period in addition to all conventional methods of treatment.
The control group will have only the conventional
Sponsors
Ain Shams University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients aged 12 to 60 years old presenting with anterior or posterior chest wall swelling and/or palpable tenderness upon examination without any significant past medical history, or with history of recurrent chest infection or multiple minor chest trauma. Ultrasound of the sternocostal swellings was required to exclude other pathologies but no specific ultrasound finding was required to confirm the clinical diagnosis. Two senior thoracic surgeons were required to establish the diagnosis.
Exclusion criteria
Exclusion criteria: 1. Patients diagnosed with myositis, coronary syndrome, chest wall tumors or mediastinal syndrome as diagnosed by clinical examination, CT chest, MRI chest or chest ultrasound. 2. Traumatic muscle pain, arthritis of sternoclavicular/sternomanubrial joints and fibromyalgia of costochondral junction. 3. Refused to be enrolled in the study or did not complete the full assessment at all time intervals.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Pain measured using the NRS at 1, 2, 3 weeks and follow up period 2. Quality of life measured using the EURO 5Q-5D-5L score at 3 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Size of joint swelling measured by patient interview at 3 weeks and 6 months after treatment. | — |
Countries
Egypt
Outcome results
None listed